CA2051840A1 - Methode de traitement de la detresse respiratoire - Google Patents

Methode de traitement de la detresse respiratoire

Info

Publication number
CA2051840A1
CA2051840A1 CA 2051840 CA2051840A CA2051840A1 CA 2051840 A1 CA2051840 A1 CA 2051840A1 CA 2051840 CA2051840 CA 2051840 CA 2051840 A CA2051840 A CA 2051840A CA 2051840 A1 CA2051840 A1 CA 2051840A1
Authority
CA
Canada
Prior art keywords
metrenperone
respiratory distress
treating respiratory
use according
distress
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA 2051840
Other languages
English (en)
Inventor
Leo A. A. Ooms
Pierre M. E. Lekeux
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceutica NV
Original Assignee
Janssen Pharmaceutica NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica NV filed Critical Janssen Pharmaceutica NV
Priority to CA 2051840 priority Critical patent/CA2051840A1/fr
Publication of CA2051840A1 publication Critical patent/CA2051840A1/fr
Abandoned legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA 2051840 1991-09-19 1991-09-19 Methode de traitement de la detresse respiratoire Abandoned CA2051840A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA 2051840 CA2051840A1 (fr) 1991-09-19 1991-09-19 Methode de traitement de la detresse respiratoire

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA 2051840 CA2051840A1 (fr) 1991-09-19 1991-09-19 Methode de traitement de la detresse respiratoire

Publications (1)

Publication Number Publication Date
CA2051840A1 true CA2051840A1 (fr) 1993-03-20

Family

ID=4148402

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2051840 Abandoned CA2051840A1 (fr) 1991-09-19 1991-09-19 Methode de traitement de la detresse respiratoire

Country Status (1)

Country Link
CA (1) CA2051840A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3106166A1 (fr) * 2008-02-29 2016-12-21 VM Therapeutics LLC Composes pour le traitement du syndrome de la douleur et autres troubles

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3106166A1 (fr) * 2008-02-29 2016-12-21 VM Therapeutics LLC Composes pour le traitement du syndrome de la douleur et autres troubles
US9834555B2 (en) 2008-02-29 2017-12-05 VM Therapeutics LLC. Method for treating pain syndrome and other disorders

Similar Documents

Publication Publication Date Title
JP3020808B2 (ja) 精神病治療薬としての４−フェニル−１，２，３，４−テトラヒドロ−１−ナフタレンアミン誘導体の使用
US6548508B2 (en) Use of PDE V inhibitors for improved fecundity in mammals
US20230241050A1 (en) Applications of hpk1 kinase inhibitor in preventing and/or treating animal pathogen infection
EP1199070A2 (fr) Utilisation d'inhibiteurs de la PDE V pour améliorer la fécondité chez les mammifères
Thompson et al. Anti-quality factors associated with alkaloids in eastern temperate pasture.
Benson et al. Intravenous anesthesia
Martineau et al. Control of Sarcoptes scabiei infestation with ivermectin in a large intensive breeding piggery
EP4094763A1 (fr) Utilisation d'un composé dans la prévention et/ou le traitement de l'infection par un pathogène chez les animaux
JP2007515402A5 (fr)
Marntell et al. Effects of additional premedication on romifidine and ketamine anaesthesia in horses
CA2051840A1 (fr) Methode de traitement de la detresse respiratoire
Horton-Smith et al. Sulphonamides in the treatment of caecal coccidiosis of chickens
Thurmon et al. Injectable anesthetics and anesthetic adjuncts
Hosein et al. Pharmacological Actions of γ-Butyrobetaine
Simone-Freilicher Use of isoxsuprine for treatment of clinical signs associated with presumptive atherosclerosis in a yellow-naped Amazon parrot (Amazona ochrocephala auropalliata)
Doherty et al. Evaluation of xylazine hydrochloride as the sole immobilizing agent in moose and caribou—and its subsequent reversal with idazoxan
US20060122105A1 (en) Method of improing the growth performance of an animal
Eme et al. Development of sympathetic cardiovascular control in embryonic, hatchling, and yearling female American alligator (Alligator mississippiensis)
Adil et al. Toxicity and Adverse Effects of Veterinary Pharmaceuticals in Animals
EP0225165A2 (fr) Utilisation de phénéthanol-amines pour améliorer la teneur en matières grasses du lait de truie
US20240116996A1 (en) Methods and compositions for treating a coronavirus infection
Abatan Combination therapy of trypanosomiasis using diminazene and non-steroidal anti-inflammatory drugs
Gill et al. An outbreak of post-vaccinal suspected distemper-like encephalitis in farmed ferrets (Mustela putorius furo)
US4213981A (en) Injectable anesthetic
Hubbell Phenothiazines and Butyrophenones

Legal Events

Date Code Title Description
FZDE Dead